Literature DB >> 12369970

Recent advances in the design of iron chelators against oxidative damage.

J B Galey1.   

Abstract

Iron imbalance plays a pivotal role in oxidative damages associated with a wide range of pathological conditions. However, owing to the essential role of iron in biological processes, the beneficial effects of iron chelation therapy against oxidative damage have to be balanced against potential toxicity. The present review briefly introduces iron redox biochemistry and oxidative-stress associated pathologies, surveys recent advances in iron chelating strategies and summarizes some of our recent findings in this field, with a special emphasis on the chemical design constraints one must satisfy in order to synthesize iron chelators which could be beneficial against oxidative stress without inducing iron depletion of the body. The concept of oxidative stress activatable iron chelators is presented as a new paradigm for safe and efficient treatment of oxidative-stress associated conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12369970     DOI: 10.2174/1389557013406846

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  7 in total

1.  Nucleotides and inorganic phosphates as potential antioxidants.

Authors:  Yael Richter; Bilha Fischer
Journal:  J Biol Inorg Chem       Date:  2006-08-01       Impact factor: 3.358

2.  Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.

Authors:  Pavlína Hašková; Hana Jansová; Jan Bureš; Miloslav Macháček; Anna Jirkovská; Katherine J Franz; Petra Kovaříková; Tomáš Šimůnek
Journal:  Toxicology       Date:  2016-10-12       Impact factor: 4.221

3.  Mfn2-Mediated Preservation of Mitochondrial Function Contributes to the Protective Effects of BHAPI in Response to Ischemia.

Authors:  Xiao-Li Chen; Guo-Ping Zhang; Sheng-Long Guo; Jia-Qi Ding; Jia-Ji Lin; Qian Yang; Zhu-Yi Li
Journal:  J Mol Neurosci       Date:  2017-09-26       Impact factor: 3.444

4.  Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine.

Authors:  Pavlína Hašková; Lenka Applová; Hana Jansová; Pavel Homola; Katherine J Franz; Kateřina Vávrová; Jaroslav Roh; Tomáš Šimůnek
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

5.  Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.

Authors:  Hana Jansová; Miloslav Macháček; Qin Wang; Pavlína Hašková; Anna Jirkovská; Eliška Potůčková; Filip Kielar; Katherine J Franz; Tomáš Simůnek
Journal:  Free Radic Biol Med       Date:  2014-06-30       Impact factor: 7.376

6.  Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.

Authors:  Hana Jansová; Jan Bureš; Miloslav Macháček; Pavlína Hašková; Anna Jirkovská; Jaroslav Roh; Qin Wang; Katherine J Franz; Petra Kovaříková; Tomáš Šimůnek
Journal:  Toxicology       Date:  2016-04-01       Impact factor: 4.221

7.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.